Nuvalent, Inc.
NUVLDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001861560
Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 292
- Q2 2026, +27 vs. previous quarter
- 13F value
- $9.29B
- Reported value at the end of Q2 2026
- Superinvestors holding
- 1
- At the end of Q2 2026
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$425.4M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q1 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Jul 15, 2026.
- Short interest
- 715.8K
- Shares sold short
- Change
- −2.19M
- −75.4% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding NUVL, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Nuvalent, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
0.5%
Nuvalent, Inc.'s share of the portfolio
- Shares
- 300,017
- Value
- $37.1M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Nuvalent, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 (view filing)4:30 PM ET | Jul 9 | 1 day | Pelish Henry E.Chief Scientific Officer | SSaleClass A Common Stock | −2.11K | $123.81 | −$261.4K | −3.2%63.5K after | 10b5-1 |
| Jul 8, 2026 (view filing)4:30 PM ET | Jul 6 | 2 days | Porter James RichardPresident and CEO | SSaleClass A Common Stock | −30.0K | $123.72 | −$3.71M | −8.5%324.9K after | 10b5-1 |
| Jul 6, 2026 (view filing)4:31 PM ET | Jul 1 | 5 days | Noci DarleneChief Development Officer | SSaleClass A Common Stock | −23.0K | $123.59 | −$2.84M | −28.4%58.1K after | 10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Balcom AlexandraChief Financial Officer | SSaleClass A Common Stock | −11.4K | $123.58 | −$1.41M | −11.8%85.5K after | 10b5-1 |
| Jul 1, 2026 (view filing)4:30 PM ET | Jun 29 | 2 days | Noci DarleneChief Development Officer | SSaleClass A Common Stock | −5.50K | $123.51 | −$679.3K | −8.6%58.1K after | 10b5-1 |
| Jun 11, 2026 (view filing) | Jun 9 | 2 days | Noci DarleneChief Development Officer | SSaleClass A Common Stock | −20.0K | $122.81 | −$2.46M | −25.6%58.1K after | 10b5-1 |
| Jun 10, 2026 (view filing) | Jun 8 | 2 days | Porter James RichardPresident and CEO | SSaleClass A Common Stock | −30.0K | $88.53 | −$2.66M | −8.5%324.9K after | 3 lots10b5-1 |
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Balcom AlexandraChief Financial Officer | SSaleClass A Common Stock | −11.4K | $98.69 | −$1.13M | −11.8%85.5K after | 8 lots10b5-1 |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Miller Deborah AnnChief Legal Officer | SSaleClass A Common Stock | −5.50K | $107.84 | −$593.1K | −8.4%59.6K after | 4 lots10b5-1 |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Noci DarleneChief Development Officer | SSaleClass A Common Stock | −5.50K | $107.80 | −$592.9K | −8.6%58.1K after | 5 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 292 holdersThe largest institutional positions in Nuvalent, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 17,248,450 | $2.13B | 22.22% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 5,924,433 | $731.7M | 13.70% | +600,000+11.3% | Added |
| BlackRock, Inc. | 5,585,619 | $689.8M | 0.01% | +760,834+15.8% | Added |
| HBK Investments L P | 3,483,100 | $430.2M | 5.00% | +3,483,100 | New |
| FIL Ltd | 2,946,506 | $363.9M | 0.26% | +2,946,441+4,532,986.2% | Added |
| Vanguard Portfolio Management LLC | 2,589,282 | $319.8M | 0.01% | +88,375+3.5% | Added |
| Vanguard Capital Management LLC | 2,459,118 | $303.7M | 0.01% | +30,630+1.3% | Added |
| State Street Corp | 2,091,044 | $258.2M | 0.01% | +55,213+2.7% | Added |
| Deep Track Capital, LP | 1,783,322 | $220.2M | 3.24% | +406,998+29.6% | Added |
| Glazer Capital, LLC | 1,769,665 | $218.6M | 5.39% | +1,769,665 | New |
Holders of 5% or more of NUVL
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Nuvalent, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G | 5.00%3.34M shares | +0.50 ppfrom 4.50% | Oct 24, 20244 filings | Jul 17, 2025 | SEC |